Cargando…
Restoration of functional PAX6 in aniridia patient iPSC-derived ocular tissue models using repurposed nonsense suppression drugs
Congenital aniridia is a rare, pan-ocular disease causing severe sight loss, with only symptomatic intervention offered to patients. Approximately 40% of aniridia patients present with heterozygous nonsense variants in PAX6, resulting in haploinsufficiency. Translational readthrough-inducing drugs (...
Autores principales: | Lima Cunha, Dulce, Sarkar, Hajrah, Eintracht, Jonathan, Harding, Philippa, Zhou, Jo Huiqing, Moosajee, Mariya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362734/ https://www.ncbi.nlm.nih.gov/pubmed/37483273 http://dx.doi.org/10.1016/j.omtn.2023.06.016 |
Ejemplares similares
-
Generation of human iPSC line (UCLi013-A) from a patient with microphthalmia and aniridia, carrying a heterozygous missense mutation c.372C>A p.(Asn124Lys) in PAX6
por: Harding, Philippa, et al.
Publicado: (2021) -
Generation of two human iPSC lines from patients with autosomal dominant retinitis pigmentosa (UCLi014-A) and autosomal recessive Leber congenital amaurosis (UCLi015-A), associated with RDH12 variants
por: Sarkar, Hajrah, et al.
Publicado: (2021) -
PAX6 disease models for aniridia
por: Abdolkarimi, Dorsa, et al.
Publicado: (2022) -
Generation of two human control iPS cell lines (UCLi016-A and UCLi017-A) from healthy donors with no known ocular conditions
por: Méjécase, Cécile, et al.
Publicado: (2020) -
Longitudinal genotype-phenotype analysis in 86 patients with PAX6-related aniridia
por: Kit, Vivienne, et al.
Publicado: (2021)